Trial Profile
DP-R212 Pharmacokinetic Study Pharmacokinetic Characteristics of DP-R212 in Comparison to Each Component Coadministered in Healthy Volunteers
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Jun 2018
Price :
$35
*
At a glance
- Drugs Amlodipine/rosuvastatin (Primary) ; Amlodipine; Rosuvastatin
- Indications Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- Sponsors Alvogen Korea
- 26 Jul 2016 New trial record